Global Blood Therapeutics gbt.com

Global Blood Therapeutics

Voxelotor for Sickle Cell Disease. About Sickle Cell Disease. GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate, voxelotor previously called GBT440, for the treatment of sickle cell disease. GBT Announces New Employment Inducement Grants. Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock.

history traffic contact

OVERVIEW

The website gbt.com presently has an average traffic ranking of zero (the lower the more traffic). We have parsed zero pages inside the web site gbt.com and found two websites associating themselves with gbt.com. There is one contacts and addresses for gbt.com to help you contact them. The website gbt.com has been online for one thousand four hundred and seventeen weeks, two days, fifteen hours, and forty-one minutes.

Links to this site

2

Contacts

1

Addresses

1

Online Since

Apr 1998

GBT.COM TRAFFIC

The website gbt.com is seeing varying levels of traffic for the duration of the year.

Date Range

1 week

1 month

3 months

This Year

Last Year

All time

Date Range

All time

This Year

Last Year

Traffic ranking by day of the week for gbt.com

Date Range

All time

This Year

Last Year

Last Month

GBT.COM HISTORY

The website gbt.com was first submitted to the registrar on April 18, 1998. It was last updated on the date of January 23, 2014. This web page will expire on the date of April 17, 2017. It is now one thousand four hundred and seventeen weeks, two days, fifteen hours, and forty-one minutes old.

REGISTERED

April

1998

UPDATED

January

2014

EXPIRED

April

2017

SPAN

27

YEARS

2

MONTHS

2

DAYS

LINKS TO WEBSITE

Global Blood Therapeutics

Enabling Extraordinary Lives for Sickle Cell Disease Patients. Transforming Treatment of Severe Blood Disorders. A Commitment to Serving Patients and Their Families. GBT440 targets the underlying mechanism of red blood cell sickling, which provides the potential to treat SCD rather than only its associated symptoms.

Laura Allen, Realtor, GRI

Laura Allen, Realtor, GRI. This Month In Real Estate. Eight steps to selling your home. How can a real estate agent help me sell my home. How to price to sell and still make a profit.

WHAT DOES GBT.COM LOOK LIKE?

CONTACTS

mcclelland, ian

215 east 24th street

new york, NY, 10010

US

1.6462869778

ianm@gbt.com

GBT.COM SERVER

I found that a single page on gbt.com took seven hundred and fifty-eight milliseconds to load. Our web crawlers could not observe a SSL certificate, so therefore our web crawlers consider gbt.com not secure.

Load time

0.758 sec

SSL

NOT SECURE

IP

69.63.141.107

NAME SERVERS

ns75.worldnic.com

ns76.worldnic.com

WEBSITE ICON

SERVER SOFTWARE AND ENCODING

We diagnosed that gbt.com is utilizing the Apache server.

SITE TITLE

Global Blood Therapeutics

DESCRIPTION

Voxelotor for Sickle Cell Disease. About Sickle Cell Disease. GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate, voxelotor previously called GBT440, for the treatment of sickle cell disease. GBT Announces New Employment Inducement Grants. Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock.

PARSED CONTENT

The website has the following on the web site, "GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities." I viewed that the web site also said " GBT is developing its late-stage product candidate, voxelotor previously called GBT440, for the treatment of sickle cell disease." They also said " GBT Announces New Employment Inducement Grants. Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock."

SEE SUBSEQUENT BUSINESSES

Global Traveler Magazine

For technical difficulties with this site, please write to Subscriber Services. You may cancel at any time during your subscription and receive a full refund for all unmailed issues. Is published by FX Express Publications, Inc. , 310 Floral Vale Blvd. , Yardley, PA 19067.

首页 - 福建师范大学闽南科技学院广播电台

Movie Top Picks 林程堪 2015-12. Movie Top Picks 林程堪 2015-11. Movie Top Picks 林程堪 2015-10. Movie Top Picks 林程堪 2015-12. Movie Top Picks 林程堪 2015-11.